SCHEMBL940907

SCHEMBL940907

C=C(C)C(=O)Oc1ccc(-c2ccc(-c3ccc(OC(=O)C(=C)C)cc3)c(C)c2)cc1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 1/20 0.48
KMT2A Q03164 2/20 0.44
ATM Q13315 1/20 0.44
HSD17B1 P14061 1/20 0.42
LMNA P02545 2/20 0.39
GAA P10253 1/20 0.39
ACACB O00763 2/20 0.39
ACACA Q13085 2/20 0.39
BACE1 P56817 1/20 0.39
SLC2A1 P11166 1/20 0.39
HSD17B10 Q99714 1/20 0.38
EPHX1 P07099 1/20 0.38
PPARG P37231 1/20 0.37
PPARA Q07869 1/20 0.37
MAPT P10636 1/20 0.37
TDP1 Q9NUW8 1/20 0.37
MAOB P27338 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
GAPDH P04406 1/20 0.35
ESR1 P03372 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21614479 0.94 BACE1 (0.48) ELANEKMT2AATMHSD17B1LMNA
SCHEMBL17309198 0.94 ELANE (0.48) ELANEKMT2AATMHSD17B1LMNA
SCHEMBL15960974 0.92 ELANE (0.49) ELANEKMT2AATMHSD17B1LMNA
SCHEMBL13967533 0.92 ELANE (0.42) ELANEKMT2AATMHSD17B1LMNA
SCHEMBL21101680 0.92 ELANE (0.43) ELANEKMT2AATMHSD17B1LMNA
SCHEMBL21469985 0.91 ELANE (0.41) ELANEKMT2AATMHSD17B1LMNA
SCHEMBL20312050 0.91 ACHE (0.42) ELANEKMT2AATMHSD17B1LMNA
SCHEMBL21470070 0.91 ELANE (0.41) ELANEKMT2AATMHSD17B1LMNA
SCHEMBL20174158 0.90 ELANE (0.43) ELANEKMT2AATMHSD17B1LMNA
SCHEMBL20275906 0.89 ELANE (0.51) ELANEKMT2AATMHSD17B1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11760934-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display element in which the compound is used DIC CORPORATION (JP) 2023-09-19 US disclosed
US-11760934-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display element in which the compound is used DIC CORPORATION (JP) 2023-09-19 US disclosed
US-20230265345-A1 LIQUID CRYSTAL COMPOSITION CONTAINING POLYMERIZABLE COMPOUND AND APPLICATION OF LIQUID CRYSTAL COMPOSITION BEIJING BAYI SPACE LCD TECHNOLOGY CO., LTD. (CN) 2023-08-24 US disclosed
US-11639327-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same DIC CORPORATION (JP) 2023-05-02 US disclosed
US-11639327-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same DIC CORPORATION (JP) 2023-05-02 US disclosed
US-11312906-B2 Polymerizable monomer, liquid crystal composition using polymerizable monomer, and liquid crystal display device DIC CORPORATION (JP) 2022-04-26 US disclosed
US-11225606-B2 Polymerizable compounds and the use thereof in liquid-crystal displays MERCK PATENT GMBH (DE) 2022-01-18 US disclosed
US-11174217-B2 Polymerizable compound and liquid crystal composition DIC CORPORATION (JP) 2021-11-16 US disclosed
US-11078421-B2 Liquid crystal composition and display using composition SHIJIAZHUANG CHENGZHI YOUNGHUA DISPLAY MATERIAL CO., LTD. (CN) 2021-08-03 US disclosed
US-20210214299-A1 POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME DIC CORPORATION (JP) 2021-07-15 US disclosed
EP-2883934-A1 Liquid-crystalline medium Merck Patent GmbH (DE) 2015-06-17 EP disclosed
US-20150069296-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME DIC CORPORATION (JP) 2015-03-12 US disclosed
US-20150069296-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME DIC CORPORATION (JP) 2015-03-12 US disclosed
EP-2843027-A1 LIQUID CRYSTAL COMPOSITION COMPRISING POLYMERIZABLE COMPOUNDS AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME DIC Corporation (JP) 2015-03-04 EP disclosed
EP-2801601-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY ELEMENT USING SAME DIC Corporation (JP) 2014-11-12 EP disclosed
US-8765013-B2 Nematic liquid crystal composition and liquid crystal display device using the same DIC CORPORATION (JP) 2014-07-01 US disclosed
US-8765013-B2 Nematic liquid crystal composition and liquid crystal display device using the same DIC CORPORATION (JP) 2014-07-01 US disclosed
US-20120292569-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME DIC CORPORATION (JP) 2012-11-22 US disclosed
US-20120292569-A1 NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME DIC CORPORATION (JP) 2012-11-22 US disclosed
US-20110007013-A1 INPUT DEVICE AND INPUT FUNCTION-EQUIPPED DISPLAY DEVICE SONY CORPORATION (JP) 2011-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11760934-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display element in which the compound is used SFXN1, SFXN3, SIK3 ELANE 3684/4885KMT2A 3540/4885ATM 4308/4885
US-11225606-B2 Polymerizable compounds and the use thereof in liquid-crystal displays VCL, PLEC, EML4 ELANE 1489/4885KMT2A 3905/4885ATM 2859/4885
US-11174217-B2 Polymerizable compound and liquid crystal composition PI4KA, PKN2, KCNH3 ELANE 2693/4885KMT2A 1009/4885ATM 3409/4885
US-20210214299-A1 POLYMERIZABLE COMPOUND, AND LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE USING THE SAME SKP1, PKN1, KTN1 ELANE 4055/4885KMT2A 1564/4885ATM 3603/4885
US-11639327-B2 Polymerizable compound, and liquid crystal composition and liquid crystal display device using the same SKP1, PKN1, KTN1 ELANE 4055/4885KMT2A 1564/4885ATM 3603/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.